glp-1 drugs mechanism of action of agonists – My Endo Consult GLP-1 and the kidney: from

Therefore, if GLP-1 RA treatment specifically increases the risk of pancreatitis in this vulnerable population, such an effect would likely remain undetected in randomized trials

Behavioural Brain Research

however, comparative studies indicate that continuous positive airway pressure (CPAP) remains significantly more effective than liraglutide when used as monotherapy.[45] Two recent randomized controlled trials involving 469 participants without diabetes and with moderate to severe OSA demonstrated a 55% reduction in AHI with tirzepatide treatment.[17] These findings led to FDA approval of tirzepatide for moderate to severe OSA in December 2024

Why the hype: Diabetes, obesity, and vascular disease are known contributors to brain aging and dementia risk

consequently, the latter induces negative feedback on the HPG axis, leading to sub-fecundity and infertility